Theranostics, An Issue of PET Clinics
- 1st Edition, Volume 21-3 - June 5, 2026
- Latest edition
- Editors: Harshad Kulkarni, Abass Alavi
- Language: English
In this issue of PET Clinics, guest editors Drs. Harshad Kulkarni and Abass Alavi bring their considerable expertise to the topic of Theranostics. Tops experts cover key topics su… Read more
Purchase options
Description
Description
In this issue of PET Clinics, guest editors Drs. Harshad Kulkarni and Abass Alavi bring their considerable expertise to the topic of Theranostics. Tops experts cover key topics such as total-body PET in theranostics: transforming treatment planning and follow-up; FAP-targeted imaging and therapy; theranostics in neuroendocrine neoplasms: integrating imaging, therapy, and dosimetry; theranostics: when targeting imaging leads to a targeted therapy; and much more.
Key features
Key features
- Contains 15 relevant, practice-oriented topics including PSMA theranostics in prostate cancer; AI and quantification in theranostics: enabling response prediction and dosimetric accuracy; theranostics in pediatric oncology; building sustainable theranostics programs; PET-based radiation therapy; state-of-the-art radioiodine theranostics of thyroid cancer; and more
- Provides in-depth clinical reviews on theranostics, offering actionable insights for clinical practice
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
Readership
Readership
Radiology, nuclear medicine
Table of contents
Table of contents
Theranostics in Nuclear Medicine: Historical, Regulatory, and Evidence Context for the Practicing Nuclear Medicine Physician
Total-Body PET in Theranostics: Reshaping Treatment Planning and Follow-Up
State-of-the-Art Theranostics of Thyroid Cancer
Theranostics in Neuroendocrine Neoplasms: The Multifaceted Aspects Integrating Imaging, Therapy, and Dosimetry
Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer – Current State and Evolving Standards
Artificial Intelligence Across the PSMA Theranostic Continuum in Prostate Cancer
Novel Theranostic Targets for Prostate Cancer Beyond Prostate-Specific Membrane Antigen
Fibroblast Activation Protein: Molecular Imaging and Beyond
Theranostics: When Targeted Imaging Guides Targeted Therapy
Role of PET in Radiation Oncology: A Theranostic Perspective on Detection of Radiation- Induced Complications
Building Sustainable Theranostics Programs: Operational Models, Access, and Equity
Total-Body PET in Theranostics: Reshaping Treatment Planning and Follow-Up
State-of-the-Art Theranostics of Thyroid Cancer
Theranostics in Neuroendocrine Neoplasms: The Multifaceted Aspects Integrating Imaging, Therapy, and Dosimetry
Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer – Current State and Evolving Standards
Artificial Intelligence Across the PSMA Theranostic Continuum in Prostate Cancer
Novel Theranostic Targets for Prostate Cancer Beyond Prostate-Specific Membrane Antigen
Fibroblast Activation Protein: Molecular Imaging and Beyond
Theranostics: When Targeted Imaging Guides Targeted Therapy
Role of PET in Radiation Oncology: A Theranostic Perspective on Detection of Radiation- Induced Complications
Building Sustainable Theranostics Programs: Operational Models, Access, and Equity
Product details
Product details
- Edition: 1
- Latest edition
- Volume: 21-3
- Published: June 5, 2026
- Language: English
About the editors
About the editors
HK
Harshad Kulkarni
Affiliations and expertise
Chief Medical Advisory, BAMF Health, Grand Rapid, Michigan, USAAA
Abass Alavi
Affiliations and expertise
Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA